Tejas Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.00 M
- Revenue Growth -27.90%
- Profit Growth -28.26%
- Ebitda 129.54%
- Net Worth 23.89%
- Total Assets -20.84%
About Tejas Speciality Chemicals
Tejas Speciality Chemicals Private Limited (TSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2014 and has a history of Ten years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Prabhakar Choudhari and Pramod Chaudhari serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2014PTC258731
- Company No.
258731
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2014
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Tejas Speciality Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhakar Choudhari  | Director | 16-Oct-2014 | Current |
| Pramod Chaudhari | Director | 16-Oct-2014 | Current |
Financial Performance of Tejas Speciality Chemicals.
Tejas Speciality Chemicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.9% decrease. The company also saw a substantial fall in profitability, with a 28.26% decrease in profit. The company's net worth Soared by an impressive increase of 23.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tejas Speciality Chemicals?
In 2020, Tejas Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2018 | Others | ₹4.00 M | Open |
How Many Employees Work at Tejas Speciality Chemicals?
Unlock and access historical data on people associated with Tejas Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tejas Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tejas Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.